This HTML5 document contains 51 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q64665288
rdf:type
wikibase:Item
schema:description
կլինիկական փորձարկում клінічне випробування clinical trial klinisch onderzoek ensayu clínicu
rdfs:label
Canakinumab Study in Individuals With Newly Diagnosed Type 1 Diabetes
skos:prefLabel
Canakinumab Study in Individuals With Newly Diagnosed Type 1 Diabetes
schema:name
Canakinumab Study in Individuals With Newly Diagnosed Type 1 Diabetes
p:P1476
wds:Q64665288-EF0DB4B6-B549-4EB7-BD5B-38D826CFE048
wdt:P1476
Effects of Canakinumab On The Progression of Type 1 Diabetes In New Onset Subjects
p:P582
wds:Q64665288-AF3C596F-0C4D-400B-91FA-95F0E0264770
wdt:P582
2013-04-01T00:00:00Z
p:P31
wds:Q64665288-569170FE-598A-4D76-B4BC-1FE9AB1F24BC
wdt:P31
wd:Q30612
p:P580
wds:Q64665288-72EA243E-3B57-4B4D-A036-FAB958AFDBE3
wdt:P580
2010-10-01T00:00:00Z
p:P17
wds:Q64665288-60661F9D-4ED7-4599-9C74-A85BF56F0349 wds:Q64665288-B748BEF2-E519-4F4A-A7EB-600E76BD292B
wdt:P17
wd:Q30 wd:Q16
p:P6153
wds:Q64665288-B407DF68-2037-4A53-981C-90F438F5FFFC wds:Q64665288-E69A5C3A-6833-4355-AFCA-9934596A2603 wds:Q64665288-71D08914-656D-48DC-B7C5-0A73A29E5BB8 wds:Q64665288-901DD8BD-64C8-4C1C-8374-488F9847DBCC wds:Q64665288-275B5542-3752-4D1A-916A-1F8D9FA87DB6 wds:Q64665288-29AD91CE-05FA-47B7-BB7D-2E91C7D9DDC5 wds:Q64665288-40317E7A-3342-4B03-8101-8BB46F82BAA8
wdt:P6153
wd:Q49112 wd:Q235034 wd:Q49088 wd:Q4886865 wd:Q41506 wd:Q501758 wd:Q238101
p:P1813
wds:Q64665288-55208E1D-A282-4867-AE06-12CA0559434B
wdt:P1813
anti IL-1
p:P2899
wds:Q64665288-F02CFA2E-8D11-4F2A-A5F6-172D936668B1
wdt:P2899
6
p:P1050
wds:Q64665288-4B7607E8-B420-44C6-97F0-1C24123DBBA9
wdt:P1050
wd:Q12206
p:P1132
wds:Q64665288-18966309-36EE-4545-823F-5AF39A80D089
wdt:P1132
71
p:P4135
wds:Q64665288-924B575D-91E2-4600-AD56-0A70F1A5B96F
wdt:P4135
45
p:P8363
wds:Q64665288-50727708-E319-4858-80AE-01F671F6B15E
wdt:P8363
wd:Q78089383
p:P3098
wds:Q64665288-91ff8523-435d-0e6d-f1a8-7a6a5a08427d
wdt:P3098
NCT00947427
p:P6099
wds:Q64665288-3016A490-7704-4943-8843-A057784BD000
wdt:P6099
wd:Q42824440